Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Maze Therapeutics, Inc. (MAZE)

Biohaven Ltd. and Maze Therapeutics, Inc. are both Biotechnology companies. Biohaven Ltd. and Maze Therapeutics, Inc. are of similar size ($1.8B and $1.8B). Across the 10 metrics below, Maze Therapeutics, Inc. leads on 8 and Biohaven Ltd. on 2.

Valuation

Metric BHVN MAZE Biotechnology median
P/E n/m n/m 8.58
P/S 2.25 n/m 10.29
P/B 182.90 4.17 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m n/m 0.67
EV/Sales 2.24 n/m 9.89
Earnings yield (31.27%) (7.87%) (31.56%)
Free cash flow yield (23.79%) (5.66%) (23.42%)

Profitability

Metric BHVN MAZE Biotechnology median
Gross margin 0.00% — 65.77%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (799.46%) (37.35%) (54.09%)
Return on assets (127.41%) (31.99%) (47.78%)
Return on invested capital (9,245.36%) (112.36%) 0.00%

Growth

Metric BHVN MAZE Biotechnology median
Revenue growth (TTM) 425.20% — 5.83%
EPS growth (last fiscal year) 26.08% (344.00%) 29.36%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BHVN MAZE Biotechnology median
Debt to equity 21.23 0.09 0.00
Current ratio 4.73 18.31 4.80
Net debt to EBITDA 0.11 2.43 0.97

Dividend

Metric BHVN MAZE Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric BHVN MAZE Biotechnology median
Market cap 1.77b 1.81b 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack